Clinical Trial Update: Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Chinese kidney transplant recipients comparing Leymovir to valganciclovir for prevention of cytomegalovirus infection and cytomegalovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Disease
• Cytomegalovirus Infection

Drugs mentioned

• Leymovir
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Kidney Transplant | Phase 4 | Status: RECRUITING